Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1989-12-1
pubmed:abstractText
Decreased responses to antigens and lectins are a characteristic feature of peripheral blood lymphocytes isolated from patients with the acquired immunodeficiency syndrome (AIDS). The in vitro addition of recombinant gamma interferon (IFN-gamma) to cultures of peripheral blood lymphocytes obtained from patients with AIDS resulted in an augmented proliferative response [( 3H]thymidine uptake) to phytohemagglutinin (PHA) and an enrichment in CD4+ and CD8+ T lymphocytes. In AIDS cultures stimulated with PHA, IFN-gamma increased the release of T-cell growth factors and enhanced the expression of interleukin-2 receptors on activated lymphocytes. Responsiveness to PHA was augmented, albeit to a lesser extent, by IFN-gamma in cultures derived from normal donors. Proliferation to microbial antigens including herpes simplex virus, cytomegalo virus, and Candida albicans was increased by IFN-gamma in cultures established from a group of AIDS patients with Kaposi's sarcoma who had no history of opportunistic infection.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-2430298, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-2857946, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-2863475, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-2903953, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-2903954, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3005400, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3018647, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3047875, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3090545, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3096401, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3122616, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3129509, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3157753, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3277274, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3838854, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-3918107, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6182091, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6200566, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6200937, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6232458, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6235286, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6296263, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6330202, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6403609, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6418799, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6422299, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6429537, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6436036, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6438249, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6439741, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6606643, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6712031, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-6835320, http://linkedlifedata.com/resource/pubmed/commentcorrection/2572558-7028425
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3619-28
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:2572558-Acquired Immunodeficiency Syndrome, pubmed-meshheading:2572558-Antigens, Bacterial, pubmed-meshheading:2572558-Antigens, CD8, pubmed-meshheading:2572558-Antigens, Differentiation, T-Lymphocyte, pubmed-meshheading:2572558-CD4-Positive T-Lymphocytes, pubmed-meshheading:2572558-Cells, Cultured, pubmed-meshheading:2572558-Humans, pubmed-meshheading:2572558-Interferon Type I, pubmed-meshheading:2572558-Interferon-gamma, pubmed-meshheading:2572558-Lectins, pubmed-meshheading:2572558-Lymphocyte Activation, pubmed-meshheading:2572558-Lymphocytes, pubmed-meshheading:2572558-Lymphokines, pubmed-meshheading:2572558-Receptors, Interleukin-2, pubmed-meshheading:2572558-Recombinant Proteins, pubmed-meshheading:2572558-Sarcoma, Kaposi, pubmed-meshheading:2572558-Statistics as Topic
pubmed:year
1989
pubmed:articleTitle
Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.
pubmed:affiliation
Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
More...